Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Nursing | Oncology | Urology | Journal

Back to Journal Articles

Process Areas for Improvement ID’d in Early Prostate Cancer

Last Updated: August 22, 2012.

 

Men undergoing expectant management have high compliance with RAND structural indicators

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
For men with early prostate cancer undergoing expectant management, compliance with RAND structural indicators is high, but there is considerable variability in compliance with process indicators, according to a study published in the September issue of The Journal of Urology.

WEDNESDAY, Aug. 22 (HealthDay News) -- For men with early prostate cancer undergoing expectant management, compliance with RAND structural indicators is high, but there is considerable variability in compliance with process indicators, according to a study published in the September issue of The Journal of Urology.

Jamie Ritchey, M.P.H., from the American College of Surgeons in Chicago, and colleagues abstracted medical records data and measured compliance with the RAND-developed quality indicators (structure and process). Data were reviewed for 13,876 men with early-stage prostate cancer undergoing expectant management in 2000 to 2001.

The researchers found that there was high compliance with structural indicators (greater than 80 percent), while compliance with process indicators varied (19 to 87 percent). Differences in process indicators were seen for models based on hospital type and comorbid conditions, but not for age, race, or insurance status.

"Using the RAND quality indicators, this study revealed several process areas for quality improvement among men with early-stage prostate cancer on expectant management in the United States," the authors write. "Efforts to improve the quality of early-stage prostate cancer care need to move beyond the paradigm of age, race, and insurance status."

One author disclosed financial ties to diagnostics manufacturers.

Abstract
Full Text
Editorial (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Mindfulness Stress Reduction Reduces Loneliness in Elderly Next: Prolonged Dexamethasone Cuts Delayed Nausea After Chemo

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.